Primary Immunodeficiency Preeda Sangacharoenkit M.D. Division of Allergy and Immunology Department of Pediatrics Bangkok Metropolitan Administrative Medical.

Slides:

Advertisements

Similar presentations

Diagnosis of Primary Immunodeficiency

Advertisements

Laboratory Testing: Innate and Adaptive Immune Systems Thomas A. Fleisher, M.D., FAAAAI, FACAAI National Institutes of Health Bethesda, MD, USA.

Slide #1 What is your clinical/academic training or background? Please select ONE answer that best describes your current primary position 1. Medical doctor.

2011 Calendar Important Dates/Events/Homework. SunSatFriThursWedTuesMon January

The Study Of Frequency Of Primary ImmunoDeficiency Disorders In Iran And Constructing A Database For Registering The Patients.

THE IMMUNE RESPONSE AGAINST INTRACELLULAR BACTERIA

Immune-deficiencies for batch 17-MBBS Yr 1 Dr. P. K. Rajesh. M.D.

D-dimer: A biomarker for antihistamine-resistant chronic urticaria

“Inflammatory skin march”: IL-1–mediated skin inflammation, atopic dermatitis, and psoriasis to cardiovascular events Keiichi Yamanaka, MD, PhD, Hitoshi.

Infections in Chronic Granulomatous Disease: 22 years' single centre experience from North India Vignesh Pandiarajan, Amit Rawat, Avinash Sharma, Deepti.

Copyright © 2017 American Academy of Pediatrics.

Von Ta, MD, Andrew A. White, MD

A Granulomatous Chronic Disease

Jessica P. Hollenbach, PhD, Michelle M. Cloutier, MD

Fatal human rabies infection confirmed with skin biopsy specimen

Role of IL-9 in the pathophysiology of allergic diseases

Biologics in patients with skin diseases

Human phagocyte defect caused by a Rac2 mutation detected by means of neonatal screening for T-cell lymphopenia Deborah Accetta, MD, Grant Syverson,

Leukocyte activation in patients with venous insufficiency

Complete remission through blast cell differentiation inPLZF/RARα-positive acute promyelocytic leukemia: in vitro and in vivo studies by Maria C. Petti,

Flow cytometric measurement of STAT1 and STAT3 phosphorylation in CD4+ and CD8+ T cells—clinical applications in primary immunodeficiency diagnostics

EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease David C. Thomas, MD, PhD, Louis-Marie Charbonnier, PhD, Andrea.

Immunodeficiency Disorders

Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

Malar Rash in a Child with Chronic Granulomatous Disease

The National Biome Initiative: An allergy perspective

Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma Bradley E. Chipps, MD, Stanley J. Szefler,

Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies Jolan E. Walter, MD, PhD, Jocelyn.

I-Hsin Kuo, MS, Takeshi Yoshida, PhD, Anna De Benedetto, MD, Lisa A

Case of Aspergillosis Treated with Amphotericin ‘B’

Repeated Episodes of Anaphylaxis with Normal Serum Tryptase but Elevated Levels of Urinary Prostaglandin D2 Phillip Lieberman, MD The Journal of Allergy.

Penicillin Skin Testing Is a Safe and Effective Tool for Evaluating Penicillin Allergy in the Pediatric Population Stephanie J. Fox, MD, Miguel A. Park,

Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies Rebecca A. Marsh, MD, Kyle M. Hebert,

Legends in allergy: Philip S. Norman and Lawrence M

Food allergy in patients with primary immunodeficiency diseases: Prevalence within the US Immunodeficiency Network (USIDNET) Karen S. Tuano, MD, Jordan.

Serum free light chains in the differential diagnosis and prognosis of primary and secondary hypogammaglobulinemia Nicolò Compagno, MD, Francesco Cinetto,

Chronic rhinosinusitis: Endotypes, biomarkers, and treatment response

Christian Hennig, MD, Christine Happle, MD, Gesine Hansen, MD

Catherine M. Pound et al. Hospital Pediatrics 2017;7:

Invasive fungal disease in autosomal-dominant hyper-IgE syndrome

Sharon Seth, MD, David A. Khan, MD

Cephalosporin Side Chain Cross-reactivity

NCF1 (p47phox)–deficient chronic granulomatous disease: comprehensive genetic and flow cytometric analysis by Douglas B. Kuhns, Amy P. Hsu, David Sun,

Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with Common Variable Immunodeficiency Phil Lieberman, MD, John Routes, MD The Journal.

Autophagy: Nobel Prize 2016 and allergy and asthma research

Administration of Intravenous Immunoglobulin to a Patient with Hypogammaglobulinemia and Anti-IgA Antibodies Phillip Lieberman, MD, Rima Rachid, MD

Advances in the approach to the patient with food allergy

Association of humoral immunodeficiency, cleidocranial dysplasia, and von Willebrand’s disease in a family cluster Pramod S. Kelkar, MD, Rosa M. Ten,

Classification system for etiology of readmission.

New pathways for itching in patients with atopic dermatitis?

Primary immunodeficiency disorder caused by phosphoinositide 3–kinase δ deficiency Georgios Sogkas, MD, PhD, Mykola Fedchenko, MD, Akshay Dhingra, MSc,

Dysregulation of innate immune receptors on neutrophils in chronic granulomatous disease Dominik Hartl, MD, Natalie Lehmann, MD, Florian Hoffmann, MD,

Von Ta, MD, Andrew A. White, MD

Xiu-Min Li, MD, LaVerne Brown, PhD

Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients Mustafa Yavuz Köker, MD, PhD, Yıldız Camcıoğlu,

Asthma, influenza, and vaccination

Primary immunodeficiency: Looking backwards, looking forwards

Advances in basic and clinical immunology in 2013

Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody.

Diagnostic testing and interpretation of tests for autoimmunity

MEDI4736 shows antitumor activity in xenograft mouse models of human cancer. MEDI4736 shows antitumor activity in xenograft mouse models of human cancer.

Advances in pediatric asthma in 2007

2015 January February March April May June July August September

Reduced klotho expression in pancreatic cancer.

Control chart demonstrating percent of patients up to date on PPSV23 out of total number of eligible clinic patients. Control chart demonstrating percent.

Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment Ruby F. Fernandez-Boyanapalli, PhD, Emilia Liana.

Itching as a systemic disease

Advances in basic and clinical immunology in 2016

Two to 20 years: female patients, continued.

E. Rand Sutherland, MD, MPH, Barry J

Presentation transcript:

Primary Immunodeficiency Preeda Sangacharoenkit M.D. Division of Allergy and Immunology Department of Pediatrics Bangkok Metropolitan Administrative Medical Colleague

Cooper et al. American Academy of Family Physicians November 2003.

Rosenzweig and Holland. J Allergy Ciln Immunol April 2004.

Evaluation of T-cell function Quantitative evaluation : T-cell subpopulation Qualitative evaluation : Delayed-type hypersensitivity (DTH) skin testing Fleisher and Oliveira. J Allergy Clin Immunol August 2004.

Evaluation of phagocytic function The nitroblue tetrazolium test (NBT) Fluorescent cytometry using the dihydrorhodamine-123 (DHR) probe Segal and Holland. Pediatric Clinics of North America December 2000.

Roos et al. Microbes and Infection 5 (2003)

Panel D shows the results of the nitroblue tetrazolium test in normal neutrophils: phagocytosis results in dark-blue staining of the cytoplasm. Panel E shows the results of the nitroblue tetrazolium test in neutrophils from a patient with chronic granulomatous disease: there is no phagocytosis and thus no dark-blue cytoplasmic staining. Lekstrom-Himes and Gallin. NEJM December 2000.

Jirapongsananuruk et al. J Allergy Clin Immunol February 2003.